Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMedOpen access

Novel 3D-Printed Biophotonic Scaffold Displaying Luminescence under Near-Infrared Light for Photopharmacological Activation and Biological Signaling Compound Release.

Ghanavati S., Opar E., Gobbo VA., Matera C., Riefolo F., Castagna R.

Laboratory Study on Scar, published in Adv Healthc Mater (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Adv Healthc Mater (2025)
Country
Germany
Reported sample size
—
Source database
PubMed
PMID
40820591
PMCID
PMC12927531
DOI
10.1002/adhm.202502163
NCT
NCT06576063

Abstract (original English)

Despite significant efforts in developing novel biomaterials to regenerate tissue, only a few of them have successfully reached clinical use. It has become clear that the next generation of biomaterials must be multifunctional. Smart biomaterials can respond to environmental or external stimuli, interact in a spatial-temporal manner, and trigger specific tissue/organism responses. In this study, the fabrication of novel 3D-printed and bioresorbable scaffolds, with embedded crystals that can convert near-infrared (NIR) light into visible light, is presented. It is demonstrated that these biophotonic scaffolds are not only bioactive and bioresorbable, but can also be promising as a platform for the controlled release or activation of photoactivated drugs locally and on demand, under illumination. The scaffolds are analyzed based on their up-conversion spectroscopic properties and their chemical stability in simulated body fluid. Furthermore, it is demonstrated that the up-conversion properties of the scaffolds are sufficient to release the signaling molecule nitric oxide (NO) and to photoisomerize the muscarinic ligand Phthalimide-Azo-Iperoxo (PAI), in a controlled manner, upon NIR light stimulus. Finally, to assess their biocompatibility for potential implantation, a preliminary study is conducted with human adipose stem cells cultured in contact with scaffolds. Live/dead assays

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Printing, Three-DimensionalHumansInfrared RaysTissue ScaffoldsNitric OxideBiocompatible MaterialsLuminescenceDrug Liberation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research